Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

This #GivingTuesday, whatever is your first priority, your second priority has to be independent media.

2021 has been one of the most dangerous and difficult years for independent journalism that we’ve ever seen. Our democracy is facing existential threats including the climate emergency, vaccine apartheid amid deadly pandemic, a global crisis for biodiversity, reproductive freedoms under assault, rising authoritarianism worldwide, and corporate-funded corruption of democracy that run beneath all of this. Giving Tuesday is a critical opportunity to make sure our journalism remains funded so that we can stay focused on all your priority issues. Please contribute today to keep Common Dreams alive and growing.

Please Help This #GivingTuesday -- Though our content is free to all, less than 1% of our readers give. We’re counting on you. Please help Common Dreams end the year strong.

Former Vermont Gov. Howard Dean speaks during an event on November 9, 2017 in Danville, Pennsylvania.

Former Vermont Gov. Howard Dean speaks during an event on November 9, 2017 in Danville, Pennsylvania. (Photo: Lisa Lake/Getty Images for Geisinger Symposium)

'Cartoon Villain Stuff': Howard Dean Urges Biden to Oppose Lifting Covid Vaccine Patents

Dean currently works in the lobbying division at Dentons, a law firm that has represented Pfizer and other industry giants.

Jake Johnson

Former Vermont governor and erstwhile Democratic presidential candidate Howard Dean is publicly urging President Joe Biden to oppose a South Africa- and India-led effort to temporarily lift coronavirus vaccine patents, a move that would help facilitate broad-based generic production of vaccines for developing nations.

In an op-ed for Barron's last month, Dean—who currently works in the lobbying division of the global law firm Dentons—claimed that India's sponsorship of the proposed intellectual property waiver is nothing more than a "thinly veiled attempt to boost its drug industry" and argued that "President Biden would be wise to reject it."

"Suspending IP protections won't speed up Covid-19 vaccine production," Dean declared. "Every drug manufacturing facility on the planet that's capable of churning out Covid-19 shots is already doing so."

But as The Intercept's Lee Fang noted Thursday, "Dean's claim that global vaccine manufacturing is already at capacity is patently false."

"Foreign firms have lined up to offer pharmaceutical plants to produce vaccines but have been forced to enter into lengthy negotiations under terms set by the intellectual property owners," Fang wrote. "The waiver, however, would allow generic drug producers to begin copying the vaccine without delay."

The Associated Press reported last month that on three continents, it found factories "whose owners say they could start producing hundreds of millions of Covid-19 vaccines on short notice if only they had the blueprints and technical know-how."

Previously a supporter of single-payer healthcare, Dean was considered a "progressive outsider" when he contended for the Democratic presidential nomination in 2004. But Dean has dramatically changed his tune since joining Dentons, a global law firm that has done work on behalf of corporations in a variety of industries, including healthcare.

"Dentons touts its work on drug intellectual property issues, noting on its website that it has represented Pfizer and other firms in the recent past," Fang pointed out. "[Dean's] official role is as a senior advisor to its government affairs practice focused on corporate healthcare clients, though as The Intercept has previously reported, he engages in almost every lobbying activity imaginable."

First introduced at the World Trade Organization (WTO) in October, South Africa and India's patent waiver proposal has since garnered the support of more than a 100 countries, hundreds of progressive advocacy organizations, U.S. members of Congress, Nobel Prize-winning economists, and the head of the World Health Organization. Predictably, the pharmaceutical industry has lobbied against the waiver.

Because the WTO operates on consensus, a small number of rich nations—including the U.S., the U.K., and members of the European Union—have been able to block the proposal, leaving large pharmaceutical companies in control of vaccine production and denying the recipes to low-income nations.

At the current rate of vaccine production and distribution, experts fear that most poor nations could take until 2024 to achieve mass inoculation against Covid-19, a delay that could allow vaccine-resistant variants to emerge and spread widely.

As Common Dreams reported last week, U.S. President Biden is now considering whether to back the patent waiver as a growing number of congressional Democrats voice support for the idea.

"The waiver is supported by over 100 countries and being opposed by only a handful of rich countries," Rep. Jan Schakowsky (D-Ill.) wrote in a Medium post last month. "The world needs as much vaccine manufacturing capacity as it can get. Time is of the essence."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

New Climate Study Predicting More Rain Than Snow in the Arctic 'Rings Alarm Bells'

"There are huge ramifications of these changes," said the lead researcher, "all of which have implications on wildlife populations and human livelihoods."

Jessica Corbett ·


As Executives Hike Prices, US Corporations Rake in Biggest Profits Since 1950

"Prices are high," said Sen. Sherrod Brown, "because corporations are raising them—so they can keep paying themselves with ever-larger executive bonuses and stock buybacks."

Jake Johnson ·


47 Groups Urge Congress to Avert 'Human Rights Failure' by Blocking Biden's Saudi Arms Sale

"The Biden administration in its very first weeks committed both to center human rights in foreign policy and to end U.S. complicity in the war in Yemen. Allowing this sale to stand breaks that commitment."

Brett Wilkins ·


Congress 'Asleep at the Switch' as Biden Continues Trump-Era Ploy to Privatize Medicare

More than 1,500 physicians warn that the experiment threatens "the future of Medicare as we know it."

Jake Johnson ·


Amid Overdose Crisis, 260+ Public Health Groups Urge Congress to Pass Life-Saving Bills

"If our leaders fail to act, another year of devastating and historic overdose deaths is inevitable," said one drug policy expert.

Julia Conley ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo